6 Jul 2020 07:00
6 July 2020
Hemogenyx Pharmaceuticals plc
("Hemogenyx Pharmaceuticals" or the "Company")
New Corporate Video and Investor Webinar
Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, is pleased to announce that a new corporate video is available to view on the Company's website and can be accessed by following the link:
https://youtu.be/LP95GWupyNA
In addition, the Company also announces that Dr Vladislav Sandler, Chief Executive Officer & Co-Founder of Hemogenyx Pharmaceuticals will host a live investor webinar on 20 July 2020 at 16:00 UK time at which he will answer questions about the Company's current activities. If you would like to register for the webinar, please follow this link:
https://us02web.zoom.us/meeting/register/tZIocuyrqj4pH9HRgZuobXLJdSDkRXUDFRDU
After registering, you will receive a confirmation email containing information about joining the meeting.
Please submit your questions in advance and not later than 17 July 2020 by emailing hemogenyx@hemogenyx.com.
Enquiries:
Hemogenyx Pharmaceuticals plc | www.hemogenyx.com |
Dr Vladislav Sandler, Chief Executive Officer & Co-Founder | headquarters@hemogenyx.com |
Peter Redmond, Director | |
SP Angel Corporate Finance LLP | Tel: +44 (0)20 3470 0470 |
Matthew Johnson, Vadim Alexandre, Soltan Tagiev | |
Peterhouse Capital Limited | Tel: +44 (0)20 7469 0930 |
Lucy Williams, Duncan Vasey, Charles Goodfellow | |
US Media enquiries | Tel: +1 (323) 646-3249 |
Lowell Goodman | lowell@corbomitecomms.com |
Hemogenyx (HEMO)